Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01763346 · ClinicalTrials.gov registry record · NA
Beta Cell Restoration Through Fat Mitigation
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT01763346 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 88 participants.
The verdict
NCT01763346, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
Weight loss achieved through gastric banding will be superior to treatment with metformin in preserving or restoring pancreatic beta cell function in people with prediabetes or mild type 2 diabetes.
Interventions
- DRUG Metformin
- DEVICE gastric banding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2013-06 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01763346
The ClinicalTrials.gov registry entry for NCT01763346 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT01763346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01763346 about?
NCT01763346 is a clinical study titled "Beta Cell Restoration Through Fat Mitigation". Weight loss achieved through gastric banding will be superior to treatment with metformin in preserving or restoring pancreatic beta cell function in people with prediabetes or mild type 2 diabetes.
What is the current status of trial NCT01763346?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2013-06. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01763346?
The interventions under investigation include: Metformin (DRUG), gastric banding (DEVICE).
Who is sponsoring clinical trial NCT01763346?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.